COVID-19 Research & Faculty Experts
Several UTSA faculty are conducting innovative research on topics related to COVID-19. Their areas of expertise are below, and all are available to discuss the impacts of the virus.
News media requests for interviews with faculty members should be directed to Joe Izbrand, Chief Communications Officer, at joe.izbrand@utsa.edu.
Infectious Disease and Drug Discovery
The South Texas Center for Emerging Infectious Diseases
The Center for Innovative Drug Discovery
UTSA Genomics Core
Artificial Intelligence, Analytics and Disease Modeling
National Security and Cyber Security
Mental Health and Wellness
Public Health, Public Policy and Societal Impact
Geo-political Impact
Education
Contacts
Media Relations
Joe Izbrand
Associate Vice President of Strategic Communications & External Affairs
210-458-8754 | joe.izbrand@utsa.edu
Research, Economic Development, and Knowledge Enterprise
Bernard Arulanandam, Ph.D., MBA
Vice President for Research, Economic Development, and Knowledge Enterprise
210-458-6859 | bernard.arulanandam@utsa.edu
Jaclyn Shaw, M.S., B.A.P.A.
Assistant Vice President for Strategic Initiatives & Research
210-458-6767 | jaclyn.shaw@utsa.edu
Government Relations
Albert Carrizalez
Assistant Vice President for Government Relations
210-458-5138 | albert.carrisalez@utsa.edu
Corporate and Foundation Relations
Shawn Farrell
Assistant Vice President of Corporate and Foundation Relations
210-458-6583 | shawn.farrell@utsa.edu
AI Consortium
The MATRIX AI Consortium for Human Well-Being conducts transformative research in the design and deployment of AI to enhance human life with an emphasis on neuro-AI, machine learning implementation, augmenting human capabilities, and securing AI. Visit the consortium's COVID-19 Research & Recovery website >>
South Texas Center for Emerging Infectious Diseases
UTSA’s South Texas Center for Emerging Infectious Diseases (STCEID) focuses on molecular microbiology, immunology, medical mycology, virology, microbial genomics, vaccine development and biodefense. One of the major areas of emphasis is on the pathogenic mechanisms of emerging infectious diseases.
Center for Innovative Drug Discovery
The Center for Innovative Drug Discovery (CIDD), a joint venture between UTSA and UT Health San Antonio, facilitates the translation of basic scientific discoveries into tangible pre-clinical candidate drugs that can be further developed into clinical therapies for human disease. The CIDD provides expertise related to small molecule drug discovery and pre-clinical development.
